We are live on ! Find out more
BHC

Bowen Hanes & Co Portfolio holdings

AUM $4.11B
1-Year Est. Return 41.61%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+41.61%
3 Year Est. Return
+119.85%
5 Year Est. Return
+166.26%
10 Year Est. Return
+656.19%
AUM
$3.73B
AUM Growth
-$81.7M
Cap. Flow
-$80.6M
Cap. Flow %
-2.16%
Top 10 Hldgs %
28.64%
Holding
159
New
8
Increased
30
Reduced
62
Closed
9

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$54M
2
CRM icon
Salesforce
CRM
+$36.5M
3
SCHW
Charles Schwab
SCHW
+$35.7M
4
BSX icon
Boston Scientific
BSX
+$31.4M
5
ITRI icon
Itron
ITRI
+$28.3M

Top Sells

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$47.5M
2
CNQ icon
Canadian Natural Resources
CNQ
+$42.3M
3
ITT icon
ITT
ITT
+$39.4M
4
ACN icon
Accenture
ACN
+$35.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$32.4M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Industrials 16.11%
3 Financials 13.41%
4 Healthcare 10.89%
5 Consumer Discretionary 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.72T
$135M 3.61%
1,003,935
-59,480
-6% -$8.2M
AAPL icon
2
Apple
AAPL
$4.9T
$125M 3.35%
499,288
-12,711
-2% -$3M
COST icon
3
Costco
COST
$423B
$118M 3.17%
128,984
-1,117
-0.9% -$1.04M
NFLX icon
4
Netflix
NFLX
$305B
$116M 3.11%
1,300,450
-15,500
-1% -$1.28M
MSFT icon
5
Microsoft
MSFT
$3.35T
$101M 2.72%
240,352
-689
-0.3% -$293K
AXP icon
6
American Express
AXP
$228B
$99.8M 2.68%
336,384
-3,510
-1% -$1.01M
LLY icon
7
Eli Lilly
LLY
$1.03T
$99.2M 2.66%
128,550
+3,236
+3% +$2.68M
ISRG icon
8
Intuitive Surgical
ISRG
$126B
$96.5M 2.59%
184,930
-345
-0.2% -$180K
PANW icon
9
Palo Alto Networks
PANW
$265B
$92.2M 2.47%
506,907
+1,023
+0.2% +$193K
TDY icon
10
Teledyne Technologies
TDY
$30.1B
$84.9M 2.28%
182,869
-3,092
-2% -$1.44M
HD icon
11
Home Depot
HD
$332B
$81.3M 2.18%
208,880
-1,050
-0.5% -$429K
TTEK icon
12
Tetra Tech
TTEK
$8.42B
$80.7M 2.16%
2,025,870
+11,145
+0.6% +$500K
MSI icon
13
Motorola Solutions
MSI
$71.5B
$78.5M 2.1%
169,810
-815
-0.5% -$387K
SPGI icon
14
S&P Global
SPGI
$122B
$78.1M 2.09%
156,859
-1,165
-0.7% -$591K
ATI icon
15
ATI
ATI
$24.8B
$75.2M 2.02%
1,366,915
+1,735
+0.1% +$102K
BX icon
16
Blackstone
BX
$102B
$75.1M 2.01%
435,651
-320
-0.1% -$55.8K
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$122B
$72.7M 1.95%
180,624
+1,740
+1% +$807K
AMZN icon
18
Amazon
AMZN
$2.53T
$72.7M 1.95%
331,357
+25,614
+8% +$5.24M
V icon
19
Visa
V
$673B
$69.9M 1.87%
221,040
+52
+0% +$15.6K
GLW icon
20
Corning
GLW
$116B
$68.6M 1.84%
1,443,969
+159,975
+12% +$7.58M
TSLA icon
21
Tesla
TSLA
$1.22T
$67.8M 1.82%
+167,825
New +$54M
TMO icon
22
Thermo Fisher Scientific
TMO
$214B
$66.6M 1.79%
128,066
+10,250
+9% +$5.64M
UNP icon
23
Union Pacific
UNP
$172B
$66.1M 1.77%
289,688
+602
+0.2% +$143K
PG icon
24
Procter & Gamble
PG
$335B
$65.9M 1.77%
393,112
-3,450
-0.9% -$588K
JPM icon
25
JPMorgan Chase
JPM
$933B
$63.3M 1.7%
264,210
+3,553
+1% +$828K

Similar funds

Bowen Hanes & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Bowen Hanes & Co held 159 positions worth $3.73B, down 2.1% from $3.81B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bowen Hanes & Co's Q4 2024 filing shows 8 new, 30 increased, 62 reduced and 9 closed positions. Its largest new stake was Tesla: 167,825 shares worth $67.8M. The largest sale was Leidos, an estimated $47.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Industrials and Financials.

  • Bowen Hanes & Co's largest Q4 2024 buy was Tesla: 167,825 shares worth $67.8M.
  • Bowen Hanes & Co added most to Charles Schwab in Q4 2024, an estimated $35.7M increase.
  • Bowen Hanes & Co's biggest Q4 2024 reduction was Canadian Natural Resources, cutting an estimated $42.3M.
  • Bowen Hanes & Co fully exited Leidos in Q4 2024, selling an estimated $47.5M.
  • Bowen Hanes & Co's ten largest holdings make up 29% of its $3.73B portfolio in Q4 2024.
  • Bowen Hanes & Co opened 8 new positions and closed 9 in Q4 2024.
  • Bowen Hanes & Co's portfolio value fell 2.1% quarter-over-quarter to $3.73B.

Based on Bowen Hanes & Co's 13F filing for Q4 2024, filed 10 Feb 2025.